CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
Scleral lenses treated with Tangible Hydra-PEG +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03417505
NCT03417505N/ACompleted
CompareCT.gov

Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

Tangible Science·interventional·Posted Jan 31, 2018·Updated Jan 18, 2020

In Brief

A clinical study evaluating Scleral lenses treated with Tangible Hydra-PEG and Untreated scleral lenses for Dry Eye and Dry Eye Syndromes. Completed, enrolled 21 participants across 3 sites.

Detailed Summary

Tangible Hydra-PEG is a novel coating technology designed to improve lens wettability, deposit resistance, and tear film breakup time. This is a randomized double masked cross-over study to examine contact lens discomfort and dry eye symptoms with Tangible Hydra-PEG treated scleral lens wear compared to untreated scleral lens wear in the dry eye patient population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye, Dry Eye Syndromes
CountriesUnited States
CollaboratorsNova Southeastern University, University of California, Davis, Illinois College of Optometry

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 31, 2018
Enrollment StartJan 30, 2018
Primary CompletionJan 4, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.4 years ago

Interventions

Scleral lenses treated with Tangible Hydra-PEGdevice

Scleral lenses treated with Tangible Hydra-PEG, a hydrophilic, PEG-based contact lens coating designed to improve lens wettability, deposit resistance, and tear film breakup time.

Untreated scleral lensesdevice

Scleral lenses without the Tangible Hydra-PEG treatment will serve as a control.